Extracellular vesicles as prognostic biomarkers: results of a neoadjuvant chemoimmunotherapy clinical trial in stage IIIA (N2) non-small-cell lung cancer (SAKK 16/14). - da Silva Y; Chiang DM; Benecke L; Pfaffl MW; Hayoz S; Chiquet S; Prince SS; Bettini A; Früh M; Mauti LA; Britschgi C; Peters S; et al. (Frontiers in immunology, 2026)